British American Tobacco Spon Ads Each Rep 1 Ord Lvl Ii (BTI) Stock
Global tobacco group with established brands and dividends. Here's the price, business snapshot, and what's worth knowing about British American Tobacco Spon Ads Each Rep 1 Ord Lvl Ii in August 2026.
British American Tobacco p.l.c. (BTI) is one of the world’s largest tobacco groups, operating across cigarettes, modern oral and vapour products, and nicotine alternatives. With a market capitalisation around $109 billion, it combines established brands and distribution networks with a strategic push into reduced‑risk products (RRPs). Investors should note the mix of steady cash generation and high dividends historically, alongside structural pressures: declining cigarette volumes in many markets, heavy regulation, taxes and litigation risk, and foreign‑exchange exposure. Growth prospects hinge on uptake of RRPs and execution in emerging markets, while cost control and pricing power help margins. This summary is educational and not personalised investment advice; tobacco stocks can be volatile and past dividend policies or performance are not guarantees of future returns. Assess suitability carefully and consider regulatory, ethical and financial risks before deciding to invest.
Why It’s Moving
BTI is under pressure as technical weakness and cautious analyst calls keep downside risk in focus
- BTI slipped below its 50-day moving average, a technical break that can trigger more selling as traders reassess near-term momentum.
- Recent analyst coverage has stayed mixed, with some brokers still flagging downside risk even as the broader consensus remains cautiously positive.
- The stock is still digesting July’s earnings update, where stronger headline growth was offset by slower second-half momentum and a cautious outlook for the business.
BTI is under pressure as technical weakness and cautious analyst calls keep downside risk in focus
- BTI slipped below its 50-day moving average, a technical break that can trigger more selling as traders reassess near-term momentum.
- Recent analyst coverage has stayed mixed, with some brokers still flagging downside risk even as the broader consensus remains cautiously positive.
- The stock is still digesting July’s earnings update, where stronger headline growth was offset by slower second-half momentum and a cautious outlook for the business.
About This Stock
BRITISH AMERICAN TOBACCO SPON ADS EACH REP 1 ORD LVL II
BTI
Current Price
$56.42
Potential 12 Month Profit
-10.84%
Sector
Consumer Non-Cyclicals
Industry
Food & Tobacco
Ticker
BTI
Market Cap
$121.70B
Potential 12 Month Profit
-10.84%
Sector
Consumer Non-Cyclicals
Industry
Food & Tobacco
Sixth Month Growth Performance
next-earnings-question
BTI’s next earnings date is expected to be October 29, 2026. The report should cover the third quarter of 2026, based on the company’s usual quarterly reporting cadence. If that date shifts, it would most likely remain in late October given the historical pattern.
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying British American Tobacco's stock, expecting significant future gains.
Financial Health
British American Tobacco is performing well with strong revenue and cash flow, indicating good financial stability.
Dividend
British American Tobacco's dividend yield of 5.88% is appealing for those seeking dividend income. If you invested $1000 you would be paid $53.40 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Shift to RRPs
Reduced‑risk products are a core growth theme as cigarette volumes decline; success depends on consumer adoption and regulatory approvals, so outcomes can vary.
Global Footprint
BTI’s wide presence gives scale benefits and diversified revenue, but exposes it to varying taxes, regulation and currency fluctuations across markets.
Product Innovation
Investment in vapour and oral technologies aims to offset long‑term decline in smoking, though commercial adoption and competitive pressure create execution risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
